At a glance
- Originator ASTA Medica [CEASED]
- Class Antihyperlipidaemics; Butyric acids; Small molecules
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 12 Dec 2002 ASTA Medica ceased operations during 2002